Septerna
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Septerna and other ETFs, options, and stocks.About SEPN
Septerna, Inc. is a clinical-stage biotechnology company, which engages in pioneering a new era of G protein-coupled receptor oral small molecule drug discovery powered by proprietary Native Complex PlatformTM. Its pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases.
CEOJeffrey T. Finer
CEOJeffrey T. Finer
Employees75
Employees75
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2019
Founded2019
Employees75
Employees75
SEPN Key Statistics
Market cap1.24B
Market cap1.24B
Price-Earnings ratio-18.24
Price-Earnings ratio-18.24
Dividend yield—
Dividend yield—
Average volume286.85K
Average volume286.85K
High today—
High today—
Low today—
Low today—
Open price$26.95
Open price$26.95
Volume0.00
Volume0.00
52 Week high$29.74
52 Week high$29.74
52 Week low$4.17
52 Week low$4.17
Stock Snapshot
The current Septerna(SEPN) stock price is $27.54, with a market capitalization of 1.24B. The stock trades at a price-to-earnings (P/E) ratio of -18.24.
On 2025-12-19, Septerna(SEPN) shares started trading at $26.95, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 286.85K.
The stock's 52-week range extends from a low of $4.17 to a high of $29.74.
The stock's 52-week range extends from a low of $4.17 to a high of $29.74.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own SEPN. This list is generated using Robinhood data, and it’s not a recommendation.